Indivior PharmaceuticalsINDV

13F holders, Q3 2025 (September 30)
1holders
$24.00avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Indivior Pharmaceuticals Inc. (INDV) in their 13F filings. The largest holder was Essential Partners LLC ($96).

Company
Indivior Pharmaceuticals Inc.
CUSIP
45579U109
Latest filing quarter
Q2 2026

History

Number of 13F holders

0100200300400 Q3 2025: 1Q3 2025Q4 2025: 12Q4 2025Q1 2026: 288Q1 2026Q2 2026: 337Q2 2026

Total Exit/New Position Q3 2025

InstitutionsTotal Value
New Positions1$96
Exits0$0

Ownership 1 holders

Essential Partners LLC 0.00% New 4 $96

"% of holder's portfolio" is INDV's weight in each manager's 13F, not the share of Indivior Pharmaceuticals Inc. the manager owns.